Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytoplasmic 60S subunit biogenesis factor ZNF622 (ZNF622) is a zinc finger motif-containing protein found in both the cytoplasm and nucleus, characterized specifically by C2H2 zinc finger motifs that are canonical DNA-binding modules, though its direct DNA binding is not confirmed[3][1]. ZNF622 is involved in the cytoplasmic maturation of the 60S ribosomal subunit, suggesting a role in ribosome assembly and protein synthesis[2][5]. In addition, ZNF622 participates in the regulation of apoptosis and cellular stress responses through interactions with signaling proteins such as ASK1 (apoptosis signal-regulating kinase 1), MPK38, and B-MYB—interactions that appear to involve redox-sensitive mechanisms[1]. Recent studies highlight its antiviral function by limiting lytic growth of human adenovirus and modulating interactions of viral core proteins with host chromatin[1]. While ZNF622 has no directly approved drugs or well-established clinical biomarker roles, it is implicated in major cellular processes relevant to cell death, stress signaling, ribosomal biogenesis, and viral infection[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytoplasmic 60S subunit biogenesis factor ZNF622 (ZNF622).